R&D&I
The Instituto de Fertilidad Clínicas Rincón (IFCR) participates in various biomedical research projects as part of our company's R&D&I plan.
Advances in preimplantation diagnosis
The IFCR was the first center in the world to perform a pre-implantation genetic diagnosis for a rare disease associated with muscular dystrophy, congenital paramyotonia.
Currently, genetic diagnoses have increased considerably, and today we can pre-diagnose more than XX diseases.
The IFCR cooperates with the Molecular Medicine Unit of Clínicas Rincón and research groups at the University of Málaga, including the one led by Dr. Reyes-Engel, an expert in Medical Genetics.
Boost for biomedical innovation
Our commitment to biomedical sciences is complemented by our services, allowing us to enhance their application in the field of reproductive medicine. Therefore, since the founding of IFCR, we have actively collaborated in basic and translational research for clinical application.
Frankly, there is no better initiative than promoting business development in strategic areas such as biotechnology to boost the creation and use of innovative technologies and transform it into new knowledge.
For all these reasons, the IFCR strongly supports the training of researchers within the framework of excellence projects and Torres Quevedo grants as part of its R&D&I business plan.
Advances in preimplantation diagnosis
The IFCR was the first center in the world to perform a pre-implantation genetic diagnosis for a rare disease associated with muscular dystrophy, congenital paramyotonia.
Currently, genetic diagnoses have increased considerably, and today we can pre-diagnose more than XX diseases.
The IFCR cooperates with the Molecular Medicine Unit of Clínicas Rincón and research groups at the University of Málaga, including the one led by Dr. Reyes-Engel, an expert in Medical Genetics.
Advances in preimplantation diagnosis
The IFCR was the first center in the world to perform a pre-implantation genetic diagnosis for a rare disease associated with muscular dystrophy, congenital paramyotonia.
Currently, genetic diagnoses have increased considerably, and today we can pre-diagnose more than XX diseases.
The IFCR cooperates with the Molecular Medicine Unit of Clínicas Rincón and research groups at the University of Málaga, including the one led by Dr. Reyes-Engel, an expert in Medical Genetics.
Boost for biomedical innovation
Our commitment to biomedical sciences is complemented by our services, allowing us to enhance their application in the field of reproductive medicine. Therefore, since the founding of IFCR, we have actively collaborated in basic and translational research for clinical application.
Frankly, there is no better initiative than promoting business development in strategic areas such as biotechnology to boost the creation and use of innovative technologies and transform it into new knowledge.
For all these reasons, the IFCR strongly supports the training of researchers within the framework of excellence projects and Torres Quevedo grants as part of its R&D&I business plan.